We are live on ! Find out more
AUTL

Autolus Therapeutics
AUTL

69 hedge funds and large institutions have $260M invested in Autolus Therapeutics in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,906% more call options, than puts

Call options by funds: $341K | Put options by funds: $17K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

63% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 8

33% more capital invested

Capital invested by funds: $195M → $260M (+$65.2M)

12% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 17

6% more funds holding

Funds holding: 65 → 69 (+4)

1.93% more ownership

Funds ownership: 61.28% → 63.21% (+1.9%)

Holders
69
Holders Change
+4
Holders Change %
+6.15%
% of All Funds
1.08%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
13
Increased
19
Reduced
17
Closed
8
Calls
$341K
Puts
$17K
Net Calls
+$324K
Net Calls Change
+$265K

Top Buyers

Rank Fund Capital Flow
1
PBA
Paradigm Biocapital Advisors
New York
+$21.9M
2
TAM
TFG Asset Management
Cayman Islands
+$4.75M
3
AAA
Affinity Asset Advisors
New York
+$3.77M
4
ECM
ExodusPoint Capital Management
New York
+$864K
5
Two Sigma Investments
Two Sigma Investments
New York
+$511K

Top Sellers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
-$8.11M
2
AC
Armistice Capital
New York
-$5.71M
3
Citadel Advisors
Citadel Advisors
Florida
-$3.27M
4
JP Morgan Chase
JP Morgan Chase
New York
-$1.04M
5
Millennium Management
Millennium Management
New York
-$663K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
51
Osaic Holdings
Arizona
$41.1K +$771 +325 +2%
William Blair & Company
52
William Blair & Company
Illinois
$31.2K – – –
UBV
53
United Bank (Virginia)
Virginia
$27.4K +$2.85K +1,200 +12%
Invesco
54
Invesco
Georgia
$25.5K +$25.4K +10,699 New
Lazard Asset Management
55
Lazard Asset Management
New York
$24K +$909 +383 +4%
FWM
56
Focused Wealth Management
New York
$11.9K – – –
Bank of America
57
Bank of America
North Carolina
$11.5K +$9.92K +4,182 +640%
QCG
58
Quadrant Capital Group
Ohio
$7.2K -$2.02K -850 -22%
LC
59
Lindbrook Capital
California
$4.61K – – –
JP Morgan Chase
60
JP Morgan Chase
New York
$4.28K -$1.04M -439,226 -100%
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
$2.92K +$2.91K +1,228 New
Fidelity Investments
62
Fidelity Investments
Massachusetts
$2.7K – – –
UIA
63
Ulland Investment Advisors
Minnesota
$2K – – –
CHA
64
Carmichael Hill & Associates
Maryland
$1.21K – – –
CAM
65
Close Asset Management
United Kingdom
$1K – – –
SOW
66
State of Wyoming
Wyoming
$714 +$214 +90 +43%
Northwestern Mutual Wealth Management
67
Northwestern Mutual Wealth Management
Wisconsin
$238 +$237 +100 New
HNB
68
Huntington National Bank
Ohio
$2 -$3.56K -1,500 -100%
Millennium Management
69
Millennium Management
New York
– -$663K -360,145 Closed
Alyeska Investment Group
70
Alyeska Investment Group
Illinois
– -$394K -214,300 Closed
CSS
71
Cubist Systematic Strategies
Connecticut
– -$246K -133,860 Closed
BHCM
72
Boulder Hill Capital Management
New York
– -$105K -57,191 Closed
Susquehanna International Group
73
Susquehanna International Group
Pennsylvania
– -$92.4K -38,947 Closed
Royal Bank of Canada
74
Royal Bank of Canada
Ontario, Canada
– -$47.4K -19,996 -100%
CC
75
Cannell Capital
Wyoming
– -$31K -16,835 Closed
1 2
3
4

AUTL Hedge Fund Activity: Q2 2023 in Review

69 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q2 2023, worth a combined $260M — up 33% from $195M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new AUTL positions and 8 closed out — a net gain of 5 holders — while 19 added to existing stakes and 17 trimmed.

The largest buyer was Paradigm Biocapital Advisors, opening a new position worth an estimated $21.9M. The largest seller was Nantahala Capital Management, cutting an estimated $8.11M.

  • 69 institutional investors held Autolus Therapeutics (AUTL) as of Q2 2023, up from 65 in Q1 2023.
  • Funds reported $260M of Autolus Therapeutics stock for Q2 2023, up 33% quarter-over-quarter.
  • 13 funds opened new Autolus Therapeutics positions in Q2 2023 and 8 closed out, a net change of +5 holders.
  • The largest Autolus Therapeutics buyer in Q2 2023 was Paradigm Biocapital Advisors, an estimated $21.9M added.
  • The largest Autolus Therapeutics seller in Q2 2023 was Nantahala Capital Management, an estimated $8.11M sold.

Based on aggregated 13F filings for Q2 2023.